These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34364043)

  • 1. Interleukin-17A (IL-17A): A silent amplifier of COVID-19.
    Maione F; Casillo GM; Raucci F; Salvatore C; Ambrosini G; Costa L; Scarpa R; Caso F; Bucci M
    Biomed Pharmacother; 2021 Oct; 142():111980. PubMed ID: 34364043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
    Leija-Martínez JJ; Huang F; Del-Río-Navarro BE; Sanchéz-Muñoz F; Muñoz-Hernández O; Giacoman-Martínez A; Hall-Mondragon MS; Espinosa-Velazquez D
    Med Hypotheses; 2020 Nov; 144():109935. PubMed ID: 32795834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Importance of the Timing of Tocilizumab Administration in Moderate to Severely Ill COVID-19: Single Centered Experience Case series.
    Tenda ED; Andrian S; Albert S; Asaf MM; Pitoyo CW; Setiati S; Subekti I
    Acta Med Indones; 2021 Jul; 53(3):319-325. PubMed ID: 34611072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is IL-6 a key cytokine target for therapy in COVID-19?
    Jones SA; Hunter CA
    Nat Rev Immunol; 2021 Jun; 21(6):337-339. PubMed ID: 33850327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skewed Cytokine Responses Rather Than the Magnitude of the Cytokine Storm May Drive Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children.
    Chang JC; Matsubara D; Morgan RW; Diorio C; Nadaraj S; Teachey DT; Bassiri H; Behrens EM; Banerjee A
    J Am Heart Assoc; 2021 Aug; 10(16):e021428. PubMed ID: 34365798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
    Lu L; Zhang H; Dauphars DJ; He YW
    Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation as fuel for acute liver injury in COVID-19.
    Effenberger M; Grander C; Grabherr F; Griesmacher A; Ploner T; Hartig F; Bellmann-Weiler R; Joannidis M; Zoller H; Weiss G; Adolph TE; Tilg H
    Dig Liver Dis; 2021 Feb; 53(2):158-165. PubMed ID: 32873520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
    Cheon SY; Koo BN
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?
    Islam H; Chamberlain TC; Mui AL; Little JP
    Front Immunol; 2021; 12():677008. PubMed ID: 34234779
    [No Abstract]   [Full Text] [Related]  

  • 15. High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis.
    Ismail MB; Åkefeldt SO; Lourda M; Gavhed D; Aricò M; Henter JI; Delprat C; Valentin H
    Cytokine; 2020 Feb; 126():154877. PubMed ID: 31629106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.
    Green HF; Khosousi S; Svenningsson P
    J Parkinsons Dis; 2019; 9(4):705-709. PubMed ID: 31524180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.
    Du P; Geng J; Wang F; Chen X; Huang Z; Wang Y
    Int J Med Sci; 2021; 18(6):1356-1362. PubMed ID: 33628091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
    Gangemi S; Tonacci A
    Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases.
    Shaikh SB; Prabhu A; Bhandary YP
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):921-928. PubMed ID: 30652654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.